BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
303 results:

  • 1. Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.
    Mouillet-Richard S; Gougelet A; Passet B; Brochard C; Le Corre D; Pitasi CL; Joubel C; Sroussi M; Gallois C; Lavergne J; Castille J; Vilotte M; Daniel-Carlier N; Pilati C; de Reyniès A; Djouadi F; Colnot S; André T; Taieb J; Vilotte JL; Romagnolo B; Laurent-Puig P
    J Transl Med; 2024 Apr; 22(1):337. PubMed ID: 38589873
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer.
    Topi G; Satapathy SR; Ghatak S; Hellman K; Ek F; Olsson R; Ehrnström R; Lydrup ML; Sjölander A
    Cell Commun Signal; 2024 Mar; 22(1):198. PubMed ID: 38549115
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
    Zhou YW; Zhao X; Ni L; Cao P; Leng WB; Zhu Q; Gou HF; Zhang J; Li XF; Qiu M
    Int Immunopharmacol; 2024 Apr; 131():111887. PubMed ID: 38503018
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
    Qian C; Yang W; Li M; Feng Y; Dai N; Luo H; Jian D; Li X; Yang Y; He Y; Wang D; Li C; Xiao H
    Eur J Surg Oncol; 2024 Apr; 50(4):108242. PubMed ID: 38460248
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
    Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
    Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
    Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021).
    Ho VKY; Deijen CL; Hemmes B; van Erning FN; Snaebjornsson P; van Triest B; Grotenhuis BA
    Int J Cancer; 2024 May; 154(9):1569-1578. PubMed ID: 38151810
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA Mutational Profiling in Patients With colorectal cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
    Innocenti F; Mu W; Qu X; Ou FS; Kabbarah O; Blanke CD; Venook AP; Lenz HJ; Rashid NU
    J Clin Oncol; 2024 Feb; 42(4):399-409. PubMed ID: 37992266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating miRNAs signature on breast cancer: the MCC-Spain project.
    Gómez-Acebo I; Llorca J; Alonso-Molero J; Díaz-Martínez M; Pérez-Gómez B; Amiano P; Belmonte T; Molina AJ; Burgui R; Castaño-Vinyals G; Moreno V; Molina-Barceló A; Marcos-Gragera R; Kogevinas M; Pollán M; Dierssen-Sotos T
    Eur J Med Res; 2023 Nov; 28(1):480. PubMed ID: 37925534
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deficiency of SR-B1 reduced the tumor load of colitis-induced or apc
    Chen Q; Wang L; Song H; Xing W; Shi J; Li Y; Wang Z; Chen J; Xie N; Zhao W
    Cancer Med; 2023 Oct; 12(19):19744-19757. PubMed ID: 37766594
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
    Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutation Profile via Next-Generation Sequencing in Patients with colorectal Adenocarcinoma and Its Clinicopathological Correlation.
    Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
    Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
    Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
    Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes.
    Lun W; Luo C
    BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Recent Developments in Diagnostic and Prognostic Biomarkers for colorectal cancer: A Narrative Review.
    Giannopoulou N; Constantinou C
    Oncology; 2023; 101(10):675-684. PubMed ID: 37364542
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
    Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
    Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.